Provider
QP61-22 Free Continuing Education for Mental Health Providers through 12/31/22
Program effective Date: Jul 27, 2022
Documents & Forms Results
Displaying 2311 - 2320 of 3590 results
Provider
QP62-22 Commercial Pharmacy Benefit Exclusion for Propel®, Propel Mini®, Sinuva®
Program effective Date: Jul 27, 2022
Provider
QP63-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Ryplazim® (plasminogen, human-tvmh)
Program effective Date: Jul 27, 2022
Provider
QP55-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2022
Program effective Date: Jul 13, 2022
Provider
QP56-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Cibinqo™ (abrocitinib)
Program effective Date: Jul 13, 2022
Provider
QP57-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Pyrukynd® (mitapivat)
Program effective Date: Jul 13, 2022
Provider
QP58-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Recorlev® (levoketoconazole)
Program effective Date: Jul 13, 2022
Provider
QP59-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Tarpeyo™ (budesonide)
Program effective Date: Jul 13, 2022
Provider
QP60-22 MHCP Pharmacy Benefit Exclusion for Camcevi™ (leuprolide)
Program effective Date: Jul 13, 2022
Provider
2022 July Bulletins
Program effective Date: Jul 01, 2022